Medscape | FDA Sends Valentine to CLL Patients Medscape There is the FCR [fludarabine, cyclophosphamide, rituximab] front-line group, and the BR [bendamustine, rituximab] front-line group, but whichever one you use, there isn't a good salvage regimen. Alemtuzumab had been approved but is now off the market. |
